Skip to main content
Premium Trial:

Request an Annual Quote

IP Update: Recent Patents Awarded to Regulus, Rutgers, Monsanto, and More

Premium

Title: Oligomeric Compounds and Compositions for Use in Modulation of Small, Non-coding RNAs

Patent Number: 8,697,663

Filed: Dec. 30, 2008

Lead Inventor: Frank Bennett, Regulus Therapeutics


Title: Cyclodextrin-modified Polyamines for Delivery of Therapeutics Molecules

Patent Number: 8,697,667

Filed: Oct. 11, 2011

Lead Inventor: Ki-Bum Lee, Rutgers University


Title: miRNA-regulated Differentiation-dependent Self-delecting Cassette

Patent Number: 8,697,851

Filed: Dec. 3, 2012

Lead Inventor: David Frendewey, Regeneron Pharmaceuticals


Title: microRNA and Methods for Inhibiting the Same

Patent Number: 8,697,859

Filed: Jan. 18, 2013

Lead Inventor: Markus Stoffel, Rockefeller University


Title: Temporal Regulation of Gene Expression by microRNAs

Patent Number: 8,697,949

Filed: June 26, 2008

Lead Inventor: Edwards Allen, Monsanto

The Scan

Interfering With Invasive Mussels

The Chicago Tribune reports that researchers are studying whether RNA interference- or CRISPR-based approaches can combat invasive freshwater mussels.

Participation Analysis

A new study finds that women tend to participate less at scientific meetings but that some changes can lead to increased involvement, the Guardian reports.

Right Whales' Decline

A research study plans to use genetic analysis to gain insight into population decline among North American right whales, according to CBC.

Science Papers Tie Rare Mutations to Short Stature, Immunodeficiency; Present Single-Cell Transcriptomics Map

In Science this week: pair of mutations in one gene uncovered in brothers with short stature and immunodeficiency, and more.